Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2003
05/29/2003US20030100496 Compositions and methods for highly efficient transfection
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100486 Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
05/29/2003US20030100106 Baculovirus produced Plasmodium falciparum vaccine
05/29/2003US20030100100 Insertional mutations in mycobacteria
05/29/2003US20030100093 Human telomerase catalytic subunit: diagnostic and therapeutic methods
05/29/2003US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100073 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
05/29/2003US20030100071 Polypeptide for use in the prevention and treatment of bacterial infections
05/29/2003US20030100060 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE)
05/29/2003US20030100051 97 human secreted proteins
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative
05/29/2003US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099934 Envelope protein for use in the treatment and prevention of viral diseases
05/29/2003US20030099726 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
05/29/2003US20030099673 Use of such polypeptides and nucleic acids encoding them as vaccines and diagnostic reagents
05/29/2003US20030099672 N Streptococcus pneumoniae polysaccharides conjugated to tetanus toxoid and p Streptococcus pneumoniae polysaccharides conjugated to diphtheria toxoid for vaccine which protects against Clostridium tetani and/or Corynebacterium diphtheriae
05/29/2003US20030099671 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
05/29/2003US20030099670 Comprises RNA-sequence encoding modified RNA-polymerase due to wild-type point mutations apy; genetic engineering; immunotherapy
05/29/2003US20030099669 Method of protein production using mitochondrial translation system
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099667 Virus modified by the insertion of cDNA of serotypes
05/29/2003US20030099665 Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
05/29/2003US20030099664 Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
05/29/2003US20030099663 Also comprises neuroactive compounds, hormones, compounds having growth hormone acitivity, and polypeptide; vaccines
05/29/2003US20030099662 Proteins
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099659 Comprises glycerides for mucosal administration; provides enhanced adhesion and absorption
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099653 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099650 Treatment of immune disorders and B cell disorders
05/29/2003US20030099643 Methods for selectively stimulating proliferation of t cells
05/29/2003US20030099636 Administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said activated form is obtained using homeopathic techniques; for example, treating drug dependence/drug withdrawal; side effect reduction
05/29/2003US20030099635 Use of oral gammaglobulin for the treatment of immune-mediated diseases
05/29/2003US20030099634 Cytotoxic T lymphocyte (CTL); two peptide epitopes, one binds to an HLA class I molecule and the other to an HLA class II molecule such that they are recognized by a cytotoxic T cell and a human helper T cell; adjuvant, and carrier
05/29/2003US20030099633 Methods and compositions for treatment of immune dysfunction disorders
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030099622 Administering a cell transplant from a donor to a recipient along with a mildly myeloablative conditioning treatment and an immune blockade treatment; prevents risk of profound neutropenia or graft-versus-host-disease (GVHD)
05/29/2003US20030099615 Porcine adenovirus E1 and E4 regions
05/29/2003US20030099613 An encoded repressor or activator and a viral nucleotide sequence for replication; preparing a vaccine for the prophylaxis of AIDS, human immunodeficiency virus
05/29/2003US20030099610 Novel uses of avian interferon gamma (ifn-y)
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/29/2003US20030099608 Human cytokine receptor
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof
05/28/2003EP1314437A1 Stabilized antibody-containing preparations
05/28/2003EP1314431A2 Newcastle disease virus for therapeutic use
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1313875A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313839A1 Immune potentiating compositions
05/28/2003EP1313772A1 New cross-linked derivatives of hyaluronic acid
05/28/2003EP1313771A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
05/28/2003EP1313769A2 Antibodies to human il-1 beta
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP1313506A1 Immunologic method for the prevention of dental caries
05/28/2003EP1313505A1 Hla binding peptides and their uses
05/28/2003EP1313504A2 Methods and compositions for inhibiting angiogenesis
05/28/2003EP1313502A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1165115B1 Modulation of vascular permeability by mean of tie2 receptor activators
05/28/2003EP0814833B1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
05/28/2003EP0592546B1 Immunodeficiency virus recombinant poxvirus vaccine
05/28/2003EP0449958B9 Meningococcal class 1 outer-membrane protein vaccine
05/28/2003CN1420930A Novel compounds
05/28/2003CN1420926A Anti-angiogenic proteins and fragments and methods of use thereof
05/28/2003CN1420923A Infection of eukaryotic cells with viruses in vitro
05/28/2003CN1420789A Compound for targeting
05/28/2003CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
05/28/2003CN1420785A Method of treating cancer with anti-neurotrophin agents
05/28/2003CN1420784A Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420169A Multifunctional anticancer recombinant adenovirus and use thereof for treating and preventing tumor
05/28/2003CN1420129A Humanized anti-CD 20 monoclonal antibody
05/28/2003CN1420128A Humanized anti-HER 2 monoclonal antibody, its preparation method and pharmaceutical composition thereof
05/28/2003CN1420125A Trichina antigen gene Ts 87 and use thereof
05/28/2003CN1419938A Fusion anticaries DNA vaccine and prepring method thereof
05/28/2003CN1419937A Immune anticaries DNA vaccine, preparing method and use thereof
05/27/2003US6570006 Bacterial gene and method of treating a gram negative bacterial infection
05/27/2003US6570004 dapE gene on Helicobacter pylori and dapE− mutant strains of Helicobacter pylori
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569902 Inhibiting initiation or development of cancer by administering an effective dose of a nitrone free radical trapping agent to a subject
05/27/2003US6569679 Recombinant viral vector capable of expressing a gene product that activates a non-cytotoxic compound into a toxic product; use in treatment of viral diseases, cancer, genetic diseases
05/27/2003US6569677 Viral genome mutations involving the recognition and binding of natural cell receptors for adenoviruses; use in human gene therapy applications
05/27/2003US6569666 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/27/2003US6569641 Which can modify transcription, replication or stability of a DNA sequence; producing stochastically generated polynucleotide sequences; expression vectors
05/27/2003US6569616 Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
1 ... 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 ... 1823